Adine R. de Keijzer

Adine R. de Keijzer

Auto-generated profile, based on publicly available information

Adine R. de Keijzer

Department of Cardiothoracic Surgery, Erasmus University Medical Centre , PO Box 2040, 3000 CA Rotterdam, The

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MNMaximiliaan Lukas Notenboom
Maximiliaan Lukas Notenboom
AKAdine R de Keijzer
Adine R de Keijzer
KVKevin M Veen
Kevin M Veen
AGArjen Gökalp
Arjen Gökalp
ABAd Bogers
Ad Bogers
JTJohanna Takkenberg
Johanna Takkenberg
To explore male–female differences in aneurysm growth and clinical outcomes in a two-centre retrospective Dutch cohort study of adult patients with ascending aortic aneurysm (AscAA). Adult patients in whom imaging of an AscAA (root and/or ascending: ≥40 mm) was performed between 2007 and 2022 were included. Aneurysm growth was analysed using repeated measurements at the sinuses of Valsalva (SoV) and tubular ascending aorta. Male–female differences were explored in presentation, aneurysm characteristics, treatment strategy, survival, and clinical outcomes. One thousand eight hundred and fifty-eight patients were included (31.6% female). Median age at diagnosis was 65.4 years (interquartile range: 53.4–71.7) for females and 59.0 years (interquartile range: 49.3–68.0) for males (P < .001). At diagnosis, females more often had tubular ascending aortic involvement (75.5% vs. 70.2%; P = .030) while males more often had SoV involvement (42.8% vs. 21.6%; P < .001). Maximum absolute aortic diameter, at any location, at diagnosis did not differ between females (45.0 mm) and males (46.5 mm; P = .388). In females, tubular ascending growth was faster (P < .001), whereas in males, SoV growth was faster (P = .005), corrected for covariates. Unadjusted 10-year survival was 72.5% [95% confidence interval (CI) 67.8%–77.6%] for females and 78.3% (95% CI 75.3%–81.3%) for males (P = .010). Twenty-three type A dissections occurred, with an incidence rate of 8.2/1000 patient-years (95% CI 4.4–14.1) in females and 2.4/1000 patient-years (95% CI 1.2–4.5) in males [incidence rate ratio females/males: 3.4 (95% CI 1.5–8.0; P = .004)]. In patients having entered a diagnostic programme, involvement of aortic segments and age- and segment-related growth patterns differ between women and men with AscAA, particularly at an older age. Unravelling of these intertwined observations will provide a deeper understanding of AscAA progression and outcome in women and men and can be used as an evidence base for patient-tailored clinical guideline development. Comparative analysis of long-term clinical outcome and segment-specific aortic growth in males and females diagnosed with an aortic root and/or ascending aortic aneurysm. AscAA, ascending aortic aneurysm.

4 February 2026 in European Heart Journal
Verified
Journal Article
Open access
AKAdine R de Keijzer
Adine R de Keijzer
FMFrederike Meccanici
Frederike Meccanici
ZKZoe A Keuning
Zoe A Keuning
FEFee A J Esser
Fee A J Esser
JBJohannes W C de Bruijn
Johannes W C de Bruijn
ABAnnemien E. van den Bosch
Annemien E. van den Bosch
Background and Aims: This study investigates the clinical course and long-term outcomes of adults with subvalvular aortic stenosis (SAS). Methods: Adults with SAS, prospectively registered in the Dutch Congenital Cor Vitia (CONCOR) registry between 2001–2019, were included. All-cause mortality, SAS (re-) operation, and cardiovascular events, including arrhythmias, heart failure, (re-)operation for aortic regurgitation (AR), were assessed. Longitudinal changes in echocardiographic peak velocity, interventricular septal thickness (IVST), and left ventricular posterior wall thickness (LVPW) were analysed using linear mixed-effects models. Differences in the history of SAS repair (operated/unoperated patients), isolated/non-isolated SAS, and sex were explored. Results: Overall, 312 patients were included [age: 26.0 (interquartile range, IQR: 20.0–35.3) years, 68.3% history of SAS repair] with a median follow-up of 16 (IQR: 10–20) years (4423 patient-years). Unadjusted survival at 15 years was lower in the operated group compared to the unoperated group (P = .009) and no significant differences were observed between sexes (P = .083) or isolated/non-isolated SAS (P = .810). The cumulative incidence of (re-)operation for AR at 15 years was 7.6% (95% CI 4.7%–11.0%). The hazard of SAS repair during follow-up was higher in the unoperated group compared to the operated group [HR 0.2 (95% CI 0.1–0.5), P < .001], after correction for covariates. Peak velocity progression was 0.1 m/s (P = .357) during the first period and 0.3 m/s (P = .032) during the second (after ±10 years). No patient showed fast progression (≥0.3 m/s/year) in peak velocity. At baseline no evidence of left ventricular hypertrophy was observed, following IVST/LVPW criteria. Conclusions: Survival of adult SAS patients with a history of SAS repair was substantially lower compared to the unoperated group, reflecting a potentially more severe SAS phenotype. Nevertheless, long-term clinical event rates were considerable. SAS remained stable, suggesting less echocardiographic follow-up may suffice, particularly in mild phenotypes without AR. Additionally, follow-up should focus on the clinical sequelae of SAS.

1 January 2025 in Open Heart
Verified
Journal Article
Open access
PDF file
AKAdine R de Keijzer
Adine R de Keijzer
ZKZoë A Keuning
Zoë A Keuning
FMFrederike Meccanici
Frederike Meccanici
RKRoland R J van Kimmenade
Roland R J van Kimmenade
JMJoost P van Melle
Joost P van Melle
ABAnnemien E. van den Bosch
Annemien E. van den Bosch
Background: Supravalvular aortic stenosis (SVAS) is a rare condition with limited data on patients beyond childhood. This study aims to investigate the clinical course and outcomes of SVAS in adults. Methods: All adult (≥18 years) patients with SVAS, prospectively registered in the Dutch Congenital Cor Vitia database between 2001 and 2019, were included. Survival and event-free survival were assessed. Evolution of peak velocity was analysed using linear mixed models. Differences in previous operated state, sex and Williams-Beuren syndrome were explored. Results: 65 patients were included (age: 23 (IQR: 20, 31) years, 31% female, 46% previous SVAS correction, 47% Williams-Beuren syndrome). The peak velocity was 2.3±1.0 m/s at inclusion. Median follow-up time was 13 (IQR: 10, 17) years. Four patients died (one patient after cardiac surgery, two of non-cardiac causes and in one patient the cause of death was unknown) resulting in a 10-year survival of 95% (95% CI 90% to 100%) and event-free survival of 83% (95% CI 74% to 93%). There were no differences in event-free survival between previous operated state (p=0.2), sex (p=0.48) or Williams-Beuren syndrome (p=0.85). 31 cardiovascular events occurred in 15 patients, with the majority being arrhythmias. All SVAS-related interventions (three surgeries in two patients) occurred in unoperated patients (7 (95% CI 2 to 21)/1000 patient years). Although no patient showed fast progression (≥0.3 m/s/year), the peak velocity evolution over time increased faster in females compared with males (first time spline: 0.8 m/s, p=0.017). Conclusion: In adulthood, SVAS patients showed a stable clinical course without rapid progression. While cardiovascular events occurred in this young cohort, they were mostly obsereved in those with additional congenital heart defects, suggesting a more optimistic view for SVAS itself. No significant differences in outcomes were observed in patients with/without Williams-Beuren syndrome. Overall, SVAS tends to follow a more benign course in adulthood compared with childhood, potentially allowing for less intensive follow-up- though follow-up should still be individualised based on associated congenital heart defects and cardiovascular risks.

13 January 2026 in Interdisciplinary CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
AKAdine R de Keijzer
Adine R de Keijzer
EWEmma van der Weijde
Emma van der Weijde
MNMaximiliaan Lukas Notenboom
Maximiliaan Lukas Notenboom
GMGianclaudio Mecozzi
Gianclaudio Mecozzi
MPMarco C Post
Marco C Post
KVKevin M Veen
Kevin M Veen
Objectives: Acute type A aortic dissection (ATAAD) carries high mortality, with emergency surgery being the cornerstone of treatment. The German Registry for Acute Type A Aortic Dissection (GERAADA)-score is advocated in guidelines to predict 30-day mortality after ATAAD surgery. This study investigates its performance in a Dutch cohort, with an emphasis on malperfusion definitions, age groups, and sex. Methods: Adults undergoing emergency surgery for ATAAD at 5 Dutch centres (2007-2024) were included in a multicentre database. External validation of the GERAADA-score was performed with these data, using discrimination (area under the curve [AUC]) and calibration (Brier score, Hosmer-Lemeshow test, and calibration plots). A logistic regression with GERAADA variables was fitted on the study population, and assumptions were checked. Subgroup analyses were conducted based on sex, age groups, and malperfusion definitions (including imaging and clinical definitions). Results: A total of 1,146 patients underwent emergency surgery for ATAAD. Observed early mortality was 16.9% (n = 194). Of 1,130 patients included in the external validation cohort, 92.2% had low-intermediate risk (GERAADA-score ≤ 30%). The GERAADA-score showed moderate discrimination (AUC = 0.649, 95% confidence interval = 0.604-0.694), with a higher AUC for younger patients (50-59 years). The malperfusion definition including ischaemia confirmed by imaging showed the best discriminative power. Calibration was good (Hosmer-Lemeshow, P = .754, Brier score = 0.131). Logistic regression identified age, catecholamine use, ventilation support, and coronary and peripheral malperfusion as independent risk factors for 30-day mortality, with signs of multicollinearity between preoperative catecholamine use and resuscitation. Conclusions: In the Dutch setting, the GERAADA-score demonstrated moderate discriminative power and good calibration across relevant subgroups. Adaptations of the GERAADA-score, including conducting a haemodynamic instability variable, may be considered to avoid redundant predictions and boost reproducibility.

12 October 2025 in Heart
Verified
Journal Article
Closed access
AKAdine R de Keijzer
Adine R de Keijzer
JTJohanna Takkenberg
Johanna Takkenberg

26 August 2026 in JTCVS Open
Verified
Journal Article
Open access
PDPichoy Danial
Pichoy Danial
AKAdine R. de Keijzer
Adine R. de Keijzer
JTJohanna J.M. Takkenberg
Johanna J.M. Takkenberg
VCVincent Chauvette
Vincent Chauvette
LKLaurent de Kerchove
Laurent de Kerchove
ELEmmanuel Lansac
Emmanuel Lansac